Company Information
CIN
Status
Date of Incorporation
15 October 1980
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
11 September 2023
Paid Up Capital
184,965,600
Authorised Capital
200,000,000
Directors
Shreekant Dattathray Sawant
Director/Designated Partner
over 2 years ago
over 2 years ago
Sharadchandra Damodar Abhyankar
Director/Designated Partner
over 2 years ago
over 2 years ago
Supriya Samar Desai
Director/Designated Partner
almost 4 years ago
almost 4 years ago
Anil Mahadev Naik
Director/Designated Partner
about 6 years ago
about 6 years ago
Albert Tauro
Director
over 9 years ago
over 9 years ago
Rakhi Shridhar Kadam
Beneficial Owner
about 10 years ago
about 10 years ago
Smita Abhayakumar Phal
Beneficial Owner
about 14 years ago
about 14 years ago
Sajit Kumar
Nominee Director
over 14 years ago
over 14 years ago
Shivanand Dattatray Sawant
Director/Designated Partner
about 45 years ago
about 45 years ago
Past Directors
Govind Guno Desai
Director
about 17 years ago
about 17 years ago
Vipul Harendra Mankad
Nominee Director
over 17 years ago
over 17 years ago
Sudhakar Keshav Rangnekar
Director
about 21 years ago
about 21 years ago
Patents
A novel high-shear wet granulation process was invented for modified release formulation of active ingredients, which involves addition of a granulating fluid into the powder dry mixture of API with or without additives other than release retarding polymer to prepare a semisolid mass. Addition of release retarding p...
Wherein R1 is Cyano group and R2 is amino group.
The present invention relates to a process of preparing amino pyridine compounds represented by structural formula V comprising reacting cyano pyridine compounds represented by structural formula IV with an oxidizing agent in the absence of base.
Wherein R1 is Cya...
A method of preparing sustained release pharmaceutical composition of 1buprofen comprising a) mixing coprocessed guar gum and sugar with Ibuprofen, at least one filler, granulating agent/binder, glident and one lubricant to form tabletting mixture; b) compressing tabletting mixture into tablets and c) coating tablet...
The present invention relates to intermediates 2-isopropoxy-4,5-dimethoxybenzoic acid compound represented by structural formula I and ethyl 2-[(2-isopropoxy-4,5-dimethoxybenzoyl)amino] thiazole-4-carboxylate compound represented by structural formula XXI and their use in the preparation of acotiamide hydrochloride ...
The invention relates to improved process for making 5-(2-chlorophenyI)-l,3-dihydro-7-nitrobenzo(l,4)-diazepin-2-one namely Clonazepam from reacting 2-(2-chloroacetamido)-5-2'-nitrobenzophenone with hexamine to from 2-(2-chloroacetamido)-5-2'-nitrobenzophenone -Hexamine complex which further treated in presence of a...
A novel process for preparation of Flupentixol comprising the condensation of
Condensation of 2-(trifluoromethyl)-9H-thioxanthen-9-one with grignard of
N,N"dimethyl aminopropyl magnesium chloride in mixture of toluene and
tetrahydrofuron to give 9[3-(dimethylamino)propyl]-2-(trifluoromethyl)-9H-thioxanthen-
9-ol...
The present invention provided a process for obtaining Flupentixol E/Z isomer ratio about 1:1 to 1: 1.4, comprising; treating Flupentixol isomeric mixture containing predominately E-isomer or Z-isomer, with base in organic solvent at a temperature ranging from 0 to 120°C.
The present invention relates to a crystalline form B of Metopimazine. The present invention further relate to a processes of preparing crystalline form B of Metopimazine and pharmaceutical composition thereof.
The present invention relates to a crystalline form E of Temazepam. The present invention further relate to a processes of preparing crystalline form E of Temazepam and pharmaceutical composition thereof.
The present invention relates to a novel intermediate compounds represented by structural formula I and their uses for the preparation of substantially pure Milnacipran hydrochloride compound represented by structural formula II.
The present invention relates to a novel one pot process of preparing tranylcypromine sulfate compound of structural formula I
The present invention provide an improved process of preparing Loprazolam mesylate comprises reacting a compound of structural formula II with an alkyl chloroformate compound of structural formula III to get a compound of structural formula IV and then converting compound of structural formula IV into Loprazolam mes...
A cost effective with commercially viable process for Isonipecotamide provided by catalytic hydrogenation of isonicotinamide in presence of platinum group elements on carbon formed by reacting palladium with organochlorine, in alcohol solvents at a temperature in the range of 25-50 °C, and isolates the product In no...
The present invention relates to a novel polymorph of Brexpiprazole, a process of preparation of crystalline Form C & pharmaceutical composition thereof.
The present invention relates to a process for the preparation of 2-Methyl sulphonyl phenothiazine compound of structural formula (I) which is intermediate of Metopimazine compound of structural formula (II).
Present invention provides a stable monohydrate form of loxapine hydrochloride compound represented by structural formula (I) and process of preparing thereof
The present invention relates to a novel crystalline form C of Fluphenazine hydrochloride. The present invention further relate to a processes of preparing novel crystalline form C of Fluphenazine hydrochloride.
The novel method related to preparation of pure Zuclopenthixol using mandelic acid by formation of mandelate salt. The method comprises dissolving a mixture of E and Z-Clopenthixol into an organic solvent, added mandelic acid to form mandelate salt, crystallized in organic solvent, subsequently carrying out alkali...
Abstract
An improved process for the preparation of substituted 3-(Acetyloxy)-7-chloro-l,3-
dihydro-5-phenyl-2H-l,4-benzodiazepin-2-one
The present invention relates to a process for preparation of substituted 3-(Acetyloxy)-7-chloro-l,3-dihydro-5-phenyl-2H-l,4-benzodiazepin-2-one, the compound represented by stru...
The present invention relates to a crystalline form C of Fludiazepam. The present invention further relate to a processes of preparing crystalline form C of Fludiazepam.
The present invention relate to crystalline form A and crystalline form B of Tiemonium methylsulphate.
The present invention relates to the process of preparation of Z-Flupentixol Decanoate, compound represented by structural formula (I) by resolution of E/Z mixture of compound of structural formula (II) through the preparation of mandelate salt of Z-Flupentixol which can be used for the preparation of the compound o...
Abstract
The present invention relates to an improved process for preparation of Rebamipide represented by structural formula I
Present invention provides one pot process forpreparing 2-(chloromethyl)-4-methyl-quinazoline compound represented by structural formula (I) which is an intermediate of linagliptin compound represented by structural formula (II).
Present invention provides a process for preparation of sitagliptin compound represented by structural formula (I) through a novel mix anhydride compound represented by structural formula (IX).
wherein R is group selected from C1 to C5 alkyl, substituted C1 to C5 alkyl, phenyl or substituted phenyl.
...
Present invention provides a process for preparation of diamino benzazepine derivative compound represented by structural formula (I) by reduction of dinitro benzazepine derivative compound represented by structural formula (II) using metal/acid as a reagent.
Wherein R is a group selected from H, -COH, -COCH3, -...
ABSTRACT
AN IMPROVED PROCESS FOR PREPARATION OF QUINAZOLINE COMPOUND
AND APPLICATION THEREOF
The present invention provides an improved process for the preparation of Quinazoline compound represented by structural formula I with high yield and high purity, is an important intermediate for synthesis of various Act...
Registered Trademarks
[Class : 5] Medicinal & Pharmaceutical Preparations Included In Class 05.
[Class : 5] Medicinal & Pharmaceutical Preparations Included In Class 05.
[Class : 5] Medicinal And Pharmaceutical Preparations Included In Class 05.
View +362 more Brands for Centaur Pharmaceuticals Private Limited.
Charges
03 May 2011
State Bank Of India
154 Crore
03 August 2006
State Bank Of India
154 Crore
27 January 2015
Tata Capital Financial Services Limited
3 Crore
26 May 2015
Tata Capital Financial Services Limited
1 Crore
10 December 2013
Tjsb Sahakari Bank Limited
2 Crore
19 March 2014
Aditya Birla Finance Limited
65 Crore
19 May 2014
Tata Capital Financial Services Limited
12 Crore
05 July 2013
Tata Capital Financial Services Limited
1 Crore
31 January 2011
Canara Bank
8 Crore
27 December 2011
Electronica Finance Limited
1 Crore
19 January 2011
State Bank Of India
10 Crore
11 December 1993
State Bank Of India
19 Crore
05 April 1988
State Bank Of India
6 Lak
09 March 2001
State Bank Of India
4 Crore
24 January 2003
State Bank Of India
19 Crore
09 August 1994
State Bank Of Inbdia
67 Lak
11 December 1993
Sbi Bank
67 Lak
29 December 2000
State Bank Of India
22 Lak
01 March 2005
State Bank Of India
5 Crore
17 November 1999
State Bank Of India
42 Crore
24 January 2003
State Bank Of India
18 Crore
26 March 2009
Axis Bank Limited
19 Crore
08 March 1995
The Economic Development Corporation Goa Daman And Diu Ltd.
8 Lak
17 December 1996
The Economic Development Corporation Of Goa Daman And Diu Ltd
1 Crore
08 September 1998
Mahrashtra State Financial Corporation
23 Lak
22 October 1986
Mahrashtra State Financial Corporation
20 Lak
24 March 1986
Canara Bank
15 Lak
18 December 1995
Canara Bank
15 Lak
03 November 1993
Canara Bank
8 Lak
02 March 1995
Canara Bank
3 Lak
11 November 1989
Canara Bank
5 Lak
24 March 1986
Canara Bank
15 Lak
22 February 1995
Canara Bank
24 Thousand
27 June 1994
Canara Bank
60 Lak
20 June 1995
The Economic Development Corporation Goa Daman And Diu Ltd.
20 Lak
03 May 2011
State Bank Of India
0
03 August 2006
State Bank Of India
0
31 January 2011
Canara Bank
0
19 January 2011
State Bank Of India
0
09 August 1994
State Bank Of Inbdia
0
24 January 2003
State Bank Of India
0
11 December 1993
Sbi Bank
0
29 December 2000
State Bank Of India
0
17 November 1999
State Bank Of India
0
22 February 1995
Canara Bank
0
27 June 1994
Canara Bank
0
11 November 1989
Canara Bank
0
24 March 1986
Canara Bank
0
24 January 2003
State Bank Of India
0
01 March 2005
State Bank Of India
0
22 October 1986
Mahrashtra State Financial Corporation
0
17 December 1996
The Economic Development Corporation Of Goa Daman And Diu Ltd
0
05 July 2013
Tata Capital Financial Services Limited
0
08 September 1998
Mahrashtra State Financial Corporation
0
26 March 2009
Axis Bank Limited
0
08 March 1995
The Economic Development Corporation Goa Daman And Diu Ltd.
0
09 March 2001
State Bank Of India
0
11 December 1993
State Bank Of India
0
05 April 1988
State Bank Of India
0
18 December 1995
Canara Bank
0
24 March 1986
Canara Bank
0
03 November 1993
Canara Bank
0
26 May 2015
Tata Capital Financial Services Limited
0
27 January 2015
Tata Capital Financial Services Limited
0
19 March 2014
Aditya Birla Finance Limited
0
19 May 2014
Tata Capital Financial Services Limited
0
10 December 2013
Tjsb Sahakari Bank Limited
0
20 June 1995
The Economic Development Corporation Goa Daman And Diu Ltd.
0
27 December 2011
Electronica Finance Limited
0
02 March 1995
Canara Bank
0
03 May 2011
State Bank Of India
0
03 August 2006
State Bank Of India
0
31 January 2011
Canara Bank
0
19 January 2011
State Bank Of India
0
09 August 1994
State Bank Of Inbdia
0
24 January 2003
State Bank Of India
0
11 December 1993
Sbi Bank
0
29 December 2000
State Bank Of India
0
17 November 1999
State Bank Of India
0
22 February 1995
Canara Bank
0
27 June 1994
Canara Bank
0
11 November 1989
Canara Bank
0
24 March 1986
Canara Bank
0
24 January 2003
State Bank Of India
0
01 March 2005
State Bank Of India
0
22 October 1986
Mahrashtra State Financial Corporation
0
17 December 1996
The Economic Development Corporation Of Goa Daman And Diu Ltd
0
05 July 2013
Tata Capital Financial Services Limited
0
08 September 1998
Mahrashtra State Financial Corporation
0
26 March 2009
Axis Bank Limited
0
08 March 1995
The Economic Development Corporation Goa Daman And Diu Ltd.
0
09 March 2001
State Bank Of India
0
11 December 1993
State Bank Of India
0
05 April 1988
State Bank Of India
0
18 December 1995
Canara Bank
0
24 March 1986
Canara Bank
0
03 November 1993
Canara Bank
0
26 May 2015
Tata Capital Financial Services Limited
0
27 January 2015
Tata Capital Financial Services Limited
0
19 March 2014
Aditya Birla Finance Limited
0
19 May 2014
Tata Capital Financial Services Limited
0
10 December 2013
Tjsb Sahakari Bank Limited
0
20 June 1995
The Economic Development Corporation Goa Daman And Diu Ltd.
0
27 December 2011
Electronica Finance Limited
0
02 March 1995
Canara Bank
0
Documents
Form MGT-7-17022021_signed
Form DPT-3-03122020-signed
Instrument(s) of creation or modification of charge;-11112020
Optional Attachment-(1)-11112020
Particulars of all joint charge holders;-11112020
Form CHG-1-11112020_signed
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20201111
List of share holders, debenture holders;-05102020
Copy of MGT-8-05102020
Form AOC-4(XBRL)-27092020_signed
Form MR-1-05062020_signed
Form MGT-14-05062020_signed
Copy of letter of consent to act as Managing Director/ Whole time Director/Manager ; -05062020
Copy of shareholders resolution-05062020
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-05062020
Particulars of all joint charge holders;-16032020
Optional Attachment-(2)-16032020
Optional Attachment-(1)-16032020
Form CHG-1-16032020_signed
Instrument(s) of creation or modification of charge;-16032020
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20200316
Form DPT-3-22112019-signed
Form BEN - 2-11092019_signed
Declaration under section 90-11092019
List of share holders, debenture holders;-04092019
Copy of MGT-8-04092019
Optional Attachment-(1)-04092019
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-04092019
Form AOC-4(XBRL)-04092019_signed
Form MGT-7-04092019_signed
